Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,448 | 30,635 | 7,495 | 10,076 | 4,637 |
| Marketable Securities | N/A | N/A | 73,688 | 44,849 | 0 |
| Receivables | N/A | 5,220 | 2,141 | 307 | 7,832 |
| Inventories | N/A | 1,785 | 1,028 | 461 | 20,322 |
| Other current assets | 16,469 | 4,142 | 6,710 | 12,181 | 0 |
| TOTAL | $29,995 | $48,689 | $95,084 | $71,414 | $35,134 |
| Non-Current Assets | |||||
| PPE Net | 3,946 | 5,202 | 5,843 | 5,910 | 4,179 |
| Intangibles | 0 | 5,250 | 6,080 | 6,910 | 46,654 |
| Other Non-Current Assets | 19,467 | 8,353 | 10,000 | 7,624 | 41,800 |
| TOTAL | $23,413 | $18,805 | $21,923 | $20,444 | $92,633 |
| Total Assets | $53,408 | $67,494 | $117,007 | $91,858 | $127,767 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,863 | 0 | 3,333 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,428 | 11,671 | 7,350 | 10,518 | 10,084 |
| Accrued Expenses | 2,870 | 3,898 | 4,626 | 4,009 | 3,334 |
| Other current liabilities | 944 | 2,041 | 3,201 | 278 | 2,682 |
| TOTAL | $38,239 | $17,610 | $18,510 | $19,544 | $19,943 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 19,278 | 15,728 | 18,383 | 0 |
| Deferred Revenues | N/A | N/A | N/A | 811 | 3,843 |
| Other Non-Current Liabilities | 3,327 | 200 | 734 | 469 | 71 |
| TOTAL | $3,327 | $19,478 | $16,462 | $21,748 | $19,206 |
| Total Liabilities | $41,566 | $37,088 | $34,972 | $41,292 | $39,149 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,279 | 42,940 | 21,113 | 20,918 | N/A |
| Common Shares | 45 | 23 | 22 | 20 | 0 |
| Retained earnings | -167,856 | -127,408 | -73,719 | -80,692 | -231,988 |
| Other shareholders' equity | 0 | 0 | -105 | -20,033 | 320,606 |
| TOTAL | $11,842 | $30,406 | $82,035 | $50,566 | $88,618 |
| Total Liabilities And Equity | $53,408 | $67,494 | $117,007 | $91,858 | $127,767 |